- Home
- EVGO vs VSTM Comparison
EVGO vs VSTM Comparison
Compare EVGO & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVGO | VSTM |
|---|---|---|
| Founded | 2010 | 2010 |
| Country | United States | United States |
| Employees | 331 | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 308.9M | 303.2M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | EVGO | VSTM |
|---|---|---|
| Price | $1.91 | $3.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | $5.23 | ★ $16.50 |
| AVG Volume (30 Days) | ★ 4.1M | 2.9M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.49 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $30,914,000.00 |
| Revenue This Year | $16.45 | $282.64 |
| Revenue Next Year | $29.44 | $72.25 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 209.14 |
| 52 Week Low | $1.64 | $3.43 |
| 52 Week High | $5.18 | $11.25 |
Technical Indicators
Market Signals| Indicator | EVGO | VSTM |
|---|---|---|
| Relative Strength Index (RSI) | 46.89 | 45.06 |
| Support Level | $1.78 | $3.55 |
| Resistance Level | $2.30 | $4.48 |
| Average True Range (ATR) | 0.10 | 0.31 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 50.00 | 47.18 |
Price Performance
Historical ComparisonAbout EVGO EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.